Latest return on equity
Stoke Therapeutics Return on equity
Stoke Therapeutics (STOK) return on equity with its verified observation date.
Direct answer
Stoke Therapeutics's return on equity is -61.1%.
The verified market snapshot reports -61.1%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 3, 2026.
Get free Stoke Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -61.1%
Explore related company data
View Stoke Therapeutics's market capitalizationView Stoke Therapeutics's price-to-book ratioView Stoke Therapeutics's 52-week price rangeView Stoke Therapeutics's revenue growthView Stoke Therapeutics's profit marginView Stoke Therapeutics's debt-to-equity ratioView all Stoke Therapeutics key metricsReturn to Stoke Therapeutics profile